about
Leishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral LeishmaniasisImmunization with the Entamoeba histolytica surface metalloprotease EhMSP-1 protects hamsters from amebic liver abscess.Identifying vaccine targets for anti-leishmanial vaccine developmentExperimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins.Vector saliva in vaccines for visceral leishmaniasis: a brief encounter of high consequence?Identification of metal dithiocarbamates as a novel class of antileishmanial agentsFrom mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE.Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis.Novel vaccine approaches for protection against intracellular pathogens.Dysfunctional adaptive immunity during parasitic infectionsTherapeutic vaccines for leishmaniasis.F1 Domain of the Leishmania (Leishmania) donovani Nucleoside Hydrolase Promotes a Th1 Response in Leishmania (Leishmania) infantum Cured Patients and in Asymptomatic Individuals Living in an Endemic Area of Leishmaniasis.Antileishmanial activity of some Brazilian plants, with particular reference to Casearia sylvestris.Identification of immunodominant Leishmania major antigenic markers of the early C57BL/6 and BALB/c mice infection stages.Evaluation of the alum-naloxone adjuvant activity against experimental murine leishmaniasis due to L. major.Perifosine Mechanisms of Action in Leishmania Species.In vitro activities of hexaazatrinaphthylenes against Leishmania sppOligopeptidase B and B2: comparative modelling and virtual screening as searching tools for new antileishmanial compounds.Vaccination with leishmania hemoglobin receptor-encoding DNA protects against visceral leishmaniasis.[Leishmania epidemiology, diagnosis, chemotherapy and vaccination approaches in the international network of Pasteur Institutes].Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs.Centrin-Deleted Leishmania donovani Parasites Help CD4+ T Cells to Acquire Th1 Phenotype and Multi-Functionality Through Downregulation of CD200-CD200R Immune Inhibitory Axis.Growth arrested live-attenuated Leishmania infantum KHARON1 null mutants display cytokinesis defect and protective immunity in mice4-(1H-Pyrazol-1-yl) benzenesulfonamide derivatives: identifying new active antileishmanial structures for use against a neglected disease.
P2860
Q26858852-9DE607AB-C8F9-4B6C-A208-28F6765EF977Q30371624-005AA9B8-A363-4A80-A7CB-BC90B03896F8Q33693899-30437223-3658-4B35-99D7-10D01399CA7CQ33732102-41C07DA5-C09A-4450-96C0-56CC537C9646Q34019064-A90D91D7-5A0E-45C1-A7E9-2CB64412E064Q35168873-4B630396-D72D-41D6-AA31-3141DF1FDD60Q35809113-55118638-E5C9-4277-8FE3-5F058D8E1DFBQ37681902-27F68C09-D228-4B75-8CF9-B507C2B46349Q38194389-25254C33-A13A-4ADF-B9B4-A60F6F012C07Q38212667-1FC3DD54-E85F-4DB7-86D4-EF80013DBD11Q38235456-D65EF28E-9B1F-41E1-959C-BA0A8F7E04E2Q38658902-3F47ABBE-1B15-436F-B063-E4D313847B83Q38876821-CA977450-F10C-4787-8D4D-4260D0EB5E20Q38971667-018AE44D-B145-449D-8F91-96413F093D52Q39017213-11945844-E0FA-4DC7-AE0B-9E93DE382924Q39196825-FF685821-57A2-4368-A0B2-E29B947F033EQ39196831-1F1B5E42-ED4A-4070-B872-182E64F8BAA4Q40392585-B90078E2-AFE2-4B87-925D-4315041B4558Q42248079-17895583-85C8-4C17-A732-66F1AEF460C5Q44872017-5AB53367-73A8-4137-ADC9-7216A3560B5DQ52566647-A71BC4EA-8ADF-4003-996D-F855A4D90DC5Q55262888-EAC1A2C0-C8D9-4028-B7B8-669114E6D467Q58803575-24BDB65C-A832-4EBD-AE44-9EB3D6CFDBB5Q58867766-710A946B-1409-44CE-AD92-5736AAD4228B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Leishmaniasis: vaccine candidates and perspectives.
@en
Leishmaniasis: vaccine candidates and perspectives.
@nl
type
label
Leishmaniasis: vaccine candidates and perspectives.
@en
Leishmaniasis: vaccine candidates and perspectives.
@nl
prefLabel
Leishmaniasis: vaccine candidates and perspectives.
@en
Leishmaniasis: vaccine candidates and perspectives.
@nl
P1433
P1476
Leishmaniasis: vaccine candidates and perspectives.
@en
P2093
Bhawana Singh
P304
P356
10.1016/J.VACCINE.2012.03.068
P407
P50
P577
2012-04-01T00:00:00Z